MedSchool: Ace Your OSCEsThe Medical Company
GET - On the App Store
Drug Guide


    Better CNS penetration than crizotinib
  • Mechanism of Action

  • Anaplastic lymphoma kinase (ALK) is a novel receptor tyrosine kinase associated with ~60% of anaplastic large-cell lymphoma and ~5% of non-small cell lung cancer. Inhibition of these receptors interrupts downstream signalling pathways and suppresses cellular proliferation.

Clinical Use

  • Indications

  • ALK-positive locally advanced or metastatic non small cell lung cancer (NSCLC).
  • Adverse Effects
  • Visual phenomena
  • Nausea / vomiting / diarrhoea
  • Neutropaenia
  • Pneumonitis
  • LFT derangement
  • Bradycardia
  • Oedema
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now

Snapshot: Initialising...